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INTRODUCTION
Cancer is one of the leading causes of mortality in 
developed and developing countries. It is expect-
ed that the incidence and burden of cancer will 
increase throughout the world due to the popu-
lation growth and aging especially in less devel-
oped countries which account for about 82% of 
the world’s population1. 
Leukemia is one of the most common cancers 
and the main cause of mortality from cancer in 
children2,3. It consists of a group of diseases char-
acterized by malignant and uncontrolled prolifer-
ation of adult leukocytes or its precursors in the 
blood and bone marrow4. This disease is a hetero-
geneous group of cancers associated with the he-
matopoietic system and includes many different 
subgroups. Four main subgroups are diagnosed 
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Abstract – Objective: The present study was conducted with the aim to investigate the inci-
dence and mortality of leukemia and their association with the Human Development Index (HDI) 
around the world in 2012. 
Materials and Methods: This study was an ecologic study in the world to assess the correlation 
between Age-Standardized Incidence Rate (ASIR) and Age Standardized Mortality Rate (ASMR) of 
leukemia with HDI and its details that include: life expectancy at birth, Mean years of schooling 
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tralia (9.4). Also, countries with the highest ASMR were State of Palestine (7.7), Iraq (6.5), Mauritius 
(6), Syrian Arab Republic (5.7), and Ethiopia (5.4). There was a statistical significant and positive 
correlation between HDI and ASIR of leukemia (r = 0.74, p ≤0.001), and HDI and ASMR of leukemia 
(r = 0.369, p ≤0.001).
Conclusions: The highest incidence of leukemia occurred in countries with high and very high 
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comparing the incidence and mortality of cancers 
worldwide20. So far, the relationships of HDI and 
some cancers have been investigated. The investi-
gation of these relationships can lead to a more ac-
curate understanding of distribution of cancer and 
its risk factors worldwide21,22. Knowledge about 
the incidence and mortality rates of leukemia and 
its relationship with the HDI can be useful for 
health planning and research activities. The pres-
ent study aimed to investigate the incidence and 
mortality of leukemia and their association with 
the HDI and its components in the world in 2012. 
MATERIALS AND METHODS
This study was an ecologic study in the world to 
assess the correlation between Age-Standardized 
Incidence Rate (ASIR) and Age Standardized 
Mortality Rate (ASMR) of leukemia with Hu-
man Development Index (HDI) and its details that 
include: life expectancy at birth, mean years of 
schooling and gross national income (GNI) per 
capita. Data about the age-specific incidence and 
mortality rate (ASR) of countries for year 2012 
get from global cancer project that available in 
(http://globocan.iarc.fr/Default.aspx)10 and Hu-
man Development Index (HDI) from Human De-
velopment Report 201323 that include information 
about HDI and its details for every country in the 
word for year 2012. The method to estimate the 
age-specific incidence and mortality rates were 
published in the global cancer project by interna-
tional agency for research on cancer10,24. 
In this study, we used the correlation bivariate 
method to assess the correlation between age-spe-
cific incidence and mortality rate (ASR) with Hu-
man Development Index (HDI) and its details 
that include: Life expectancy at birth, mean years 
of schooling and gross national income (GNI) 
per capita. Statistical significance was assumed 
if p<0.05. All reported p-values are two-sided. 
Statistical analyses were performed using SPSS 
(Version 15.0, SPSS Inc, Chicago, IL, USA).
RESULTS
IncIdence of LeukemIa
In 2012, there were 351965 cases of leukemia 
of which 200676 cases occurred in males and 
151289 in females (Sex Ratio= 1.32). Among all 
cases, 130469 cases occurred in countries with 
very high HDI, 58981 cases in countries with high 
HDI, 136378 cases in countries with moderate 
HDI, and 26004 cases in countries with low HDI. 
including Acute Lymphoblastic Leukemia (ALL), 
Acute Myeloid Leukemia (AML), Chronic Lym-
phocytic Leukemia (CLL), and Chronic Myeloid 
Leukemia (CML)5-9. 
In 2012, leukemia was reported as the 14th 
most common cancer and the 11th leading cause 
of mortality from cancer worldwide. This dis-
ease was ranked 10th in men and 11th in women 
in terms of incidence, and 8th in men and 9th in 
women in terms of mortality1. In general, this dis-
ease accounts for 2.5% of the total cancer cases 
and 2.3% of the total cancer mortality in people 
under the age of 75 years10. Despite the fact that 
leukemia is the most common malignancy among 
the people under the age of 20 years11, most leuke-
mia cases occur in the elderly, so that the highest 
incidence of this disease is observed in the age 
group of 65 and older. The Acute Lymphoblastic 
Leukemia (ALL) is the most common type of this 
disease in children, so that this type of illness ac-
counts for 73% of all cases of leukemia in chil-
dren, while the acute myeloid leukemia (AML) is 
the most common type of disease in people aged 
20 to 40 years, and Chronic lymphocytic leuke-
mia (CLL) and Chronic myeloid leukemia (CML) 
are more observed in the elderly12. 
Despite recent advances in understanding the 
pathophysiology of leukemia, the risk factors of 
this disease have not been fully and clearly diag-
nosed. However, some of the potential risk factors 
of this disease are obesity, overweight, smoking, 
exposure to benzene and high dose of ionizing ra-
diation. These risk factors can be classified into 
several subgroups including the familial and ge-
netic, lifestyle and environmental risk factors13-16. 
Unlike other types of cancer, leukemia is not 
a solid tumor that a physician can remove by sur-
gery. In fact, the bone marrow is the source of this 
problem, thus its treatment is much more complex 
than other cancers17. The 5-year survival rate of 
Acute Lymphoblastic Leukemia (ALL) increased 
from 41% in the mid-1970s to 70% during 2004-
2010, mostly due to the development of treatment 
protocols including the discovery of new therapies 
with better efficacy than previous treatments18. 
However, more than 50% of young people and 
90% of the elderly die from leukemia in the first 
5 years after diagnosis of disease. The resistance 
to primary treatment and relapse of diseases after 
complete recovery are the main barriers to treat-
ment19. 
The socioeconomic status, educational level 
and life expectancy are among the reasons for 
difference in the incidence and mortality rates 
of cancers in different regions and they can be 
investigated using the Human Development In-
dex (HDI). The HDI is a useful classification for 
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leukemia in females were respectively China with 
22123 cases, India with 10644 cases, the United 
States with 10575 cases, Indonesia with 3806 cas-
es, and Russia with 3614 cases.
 
The age- STandardIzed
morTaLITy raTeS(aSmr) of LeukemIa
The ASMR of Leukemia per 100,000 people in the 
world was 3.4 (in men was 4.1 and in women was 
2.8). The ASMR of Leukemia was 3.5 in coun-
tries with very high HDI, 3.8 in countries with 
high HDI, 3.2 in countries with moderate HDI, 
and 2.4 in countries with low HDI. Five countries 
with the highest ASMR of Leukemia were respec-
tively State of Palestine with a rate of 7.7, Iraq with 
6.5, Mauritius with 6, Syrian Arab Republic with 
5.7, and Ethiopia with 5.4. Five countries with the 
highest ASMR of Leukemia for males were State 
of Palestine with a rate of 8.7, French Guiana with 
7.6, Iraq with 7.6, Syrian Arab Republic with 6.9, 
and Yemen with 6.9. There were also five coun-
tries with the highest ASMR of Leukemia for fe-
males as follows: State of Palestine with a rate of 
6.7, Iraq with 5.8, Mauritius with 5.4, Timor-Leste 
with 5.4, and Ethiopia with 5.1.
The reLaTIonShIp BeTween aSIr
of LeukemIa and hdI
There was a statistical significant and positive cor-
relation equal to 0.74 (p<0.001) between the ASIR 
of Leukemia and the HDI. Furthermore, there was 
a positive correlation between components of the 
HDI and the ASIR of Leukemia, so that there was 
a positive correlation of 0.726 (p ≤ 0.001) between 
the ASIR and life expectancy at birth, and with av-
erage education years equal to 0.672 (p ≤ 0.001), 
and with the income level per person in the popula-
tion equal to 0.507 (p ≤ 0.001) (Figure 1).
The reLaTIonShIp BeTween aSmr
of LeukemIa and hdI
There was a statistical significant and positive 
correlation equal to 0.369 (p ≤0.001) between 
ASMR of Leukemia and HDI. Furthermore, there 
was a positive correlation between components of 
HDI and ASMR of Leukemia, so that there was a 
positive correlation of 0.471 (p ≤0.001) between 
the ASMR and life expectancy at birth, and with 
average education years equal to 0.313 (p ≤0.001), 
and with the income level per person in the popu-
lation equal to 0.133 (p ≤0.001) (Figure 2).
Five countries with the highest number of leu-
kemia were China with 65778 cases, the United 
States with 39658 cases, India with 32532 cases, 
Russia with 11773 cases, and Germany with 11038 
cases. Five countries with the highest number of 
leukemia in males were respectively China with 
38394 cases, the United States with 22433 cases, 
India with 19619 cases, Germany with 6271 cases 
and Japan with 6046 cases. Five countries with 
the highest number of Leukemia in females were 
China with 27384 cases, the United States with 
17225 cases, India with 12913 cases, Russia with 
5903 cases, and Germany with 4767 cases. 
The age- STandardIzed IncIdence
raTeS (aSIr) of LeukemIa
The ASIR of leukemia per 100,000 people in the 
world was 4.7 (in men was 5.6 and in women was 
3.9). The ASIR of leukemia was 7.2 in countries 
with very high HDI, 5.4 in countries with high 
HDI, 3.8 in countries with moderate HDI, and 2.5 
in countries with low HDI. Five countries with 
the highest ASIR of leukemia were respectively 
Mauritius with a rate of 12, Cyprus with 9.5, Can-
ada with 9.5, Ireland with 9.4, and Australia with 
9.4. Five countries with the highest ASIR of Leu-
kemia for males were Ireland with a rate of 12.5, 
Mauritius with 12.5, Australia with 11.7, Canada 
with 11.5, and Cyprus with 11.5. There were also 
five countries with the highest ASIR of Leukemia 
for females as follows: Mauritius with a rate of 
11.5, Cyprus with 7.7, Canada with 7.6, Lithuania 
with 7.6, and New Zealand with 7.3. 
morTaLITy of LeukemIa
In 2012, there were 265471 deaths from leuke-
mia of which 151231 cases occurred in males 
and 11450 cases in females worldwide (Sex Ra-
tio=1.32). Among all cases, 84885 cases occurred 
in countries with very high HDI, 42847 cases in 
countries with high HDI, 113783 cases in coun-
tries with moderate HDI, and 23865 cases in 
countries with low HDI. Five countries with the 
highest number of mortality from Leukemia were 
China with 54719 cases, India with 2712 cases, 
The United States with 24729 cases, Japan with 
8583 cases, and Indonesia with 8479 cases. Five 
countries with the highest number of mortality 
from leukemia in males were respectively Chi-
na with 32596 cases, India with 16068 cases, the 
United States with 14154 cases, Japan with 5066 
cases, and Indonesia with 4673 cases. Five coun-
tries with the highest number of mortality from 
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most common childhood cancer and accounts for 
about 30% of whole cancer in the age group of 
less than 15 years31-33. 
In the present study, countries with the highest 
ASIR of leukemia were put in the rank of coun-
tries with high HDI in terms of development in-
dex, and those with the highest mortality from 
leukemia were put in the rank of countries with 
moderate and very high HDI. The results of a 
study in the United States also indicated that the 
incidence of some cancers including leukemia 
was increased in both men and women over the 
period of 2007-201133, as chronic lymphocytic 
leukemia was the most common type of leukemia 
DISCUSSION
In general, 351965 new cases and 265471 deaths 
from leukemia were recorded in the world in 
2012, and the sex ratio (male to female) was 1.32 
for incidence and mortality of leukemia. This 
difference may be due to the differences in the 
anti-oxidative capacity, sex chromosomes, gene 
expression, hormones, behavior, the availability 
and use of healthcare and differences in the en-
vironmental exposure such as higher prevalence 
of alcohol consumption and smoking in men than 
women25-30. Therefore, leukemia occurs in both 
genders and all age groups, but this disease is the 
Fig. 1. Correlation between Human De-
velopment Index (HDI) and ASIR of 
leukemia in the world in 2012.
Fig. 2. Correlation between Human De-
velopment Index (HDI) and ASMR for 
Leukemia in the world in 2012.
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in the educational level was associated with a de-
crease in the prevalence of cigarette smoking, and 
this could lead to a reduction in the incidence of 
cancer in people with higher education levels. The 
mortality rate from cancer was also significantly 
affected by the educational level45. The education-
al level might be related to behavior, health con-
ditions or access to knowledge and resources that 
had direct and indirect impact on the survival of 
the cancer46-50. The results of another study also 
showed that the rate of cancer survival was great-
er in people with higher education than those with 
low education50. 
In this study, there was a positive and signif-
icant correlation between the ASIR of leukemia 
and income level Gross Domestic Product per 
Capita (GDP), as another component of the HDI. 
Similar results were observed in other research-
es51. However, other studies found that the family 
income had an inverse relationship with the risk 
of childhood leukemia52. It seemed that the direc-
tion of the relationship was largely dependent on 
design of study, place, time and difference in the 
evaluation of socioeconomic status (SES) level 
methods53-55. 
In this study, there was a positive and signifi-
cant correlation between the ASMR of leukemia 
and income level (GDP). Evidence suggests that 
the income has an inverse relationship with leu-
kemia deaths, since in societies with a higher so-
cio-economic level, early detection can improve 
the patients’ survival50. For example, a study in 
Sweden showed that in this country, like many 
other developed countries, individuals with high-
er social and economic levels suffer from lower 
rates of chronic illness, which will ultimately lead 
to greater success in treating and improving the 
survival of cancer in these patients56,57.
CONCLUSIONS
The highest incidence of leukemia occurred in 
countries with very high and high HDI. The high-
est mortality rate occurred in countries with very 
high and moderate HDI. There was a significant 
relationship between ASIR and ASMR of leuke-
mia with the HDI and its dimensions. Therefore, 
it is necessary to investigate the causes of this 
cancer in order to reduce the incidence and mor-
tality of leukemia, especially in areas with high 
incidence and mortality.
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in adults in the Western countries; and about 30% 
of all leukemia cases were related to this type of 
disease. In contrast, this type of leukemia is rare 
in Asia and includes less than 5% of all cases34. 
The air pollution is a possible risk factor for leu-
kemia especially in developed countries. Accord-
ing to the conducted study in Canada, one of the 
chemical compounds of air pollution called nitro-
gen dioxide (NO2) is associated with leukemia
35. 
Studies in Michigan and China36,37 also showed 
that an increased risk of mortality from leukemia 
was associated with exposure to benzene. Other 
risk factors for leukemia were smoking, over-
weight and obesity which were more prevalent in 
developed countries and were associated with in-
creased incidence and mortality of leukemia and 
all of its types in adults, especially in men. It is 
also likely that the increased risk of leukemia in 
obese people is due to other behavioral factors as-
sociated with the obesity4,38. 
Life expectancy at birth is a dimension of the 
HDI and has a positive and significant correlation 
with ASIR of leukemia. Other investigations also 
showed a positive correlation between the ASIR 
of cancer and life expectancy at birth, so that the 
highest incidence of cancer was related to Europe, 
and it had the highest life expectancy (76.8 years) 
among multiple regions of WHO, but the lowest 
incidence rate for all cancers was seen in Afri-
ca with the lowest life expectancy (60 years)39. 
Therefore, the cancer is a disease associated with 
age, and despite the fact that leukemia is the most 
common malignancy in children, most cases of 
leukemia occur in the elderly12. 
In the present study, there was a positive cor-
relation between the life expectancy at birth and 
the ASMR from leukemia. In general, survival 
rates were reduced with increasing of age and 
life expectancy, especially for AML, which was 
the most common type of leukemia in adults40, 41. 
The mortality from the ALL, CLL and CML also 
increased with age42, because the effect of treat-
ment was lower on older people, and they could 
not tolerate aggressive therapies and their condi-
tions that might be a serious threat to their lives43. 
Physicians might also be less likely to treat older 
people with aggressive therapies44. 
In the present study, there was a positive and 
significant correlation between the ASIR and 
ASMR of leukemia with the average years of ed-
ucation in the societies. However, some studies 
reported a negative correlation between the level 
of education and the incidence and mortality of 
leukemia. The level of education was related to 
exposure to important risk factors of cancer such 
as smoking and obesity45. The results of a study in 
the United States also indicated that an increase 
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